Evidence map›Paper›PMID 30467522›Full record

ArticleF1000Research2018

Using Lamin B1 mRNA for the early diagnosis of hepatocellular carcinoma: a cross-sectional diagnostic accuracy study.

Amani M Abdelghany, Nasser Sadek Rezk, Mona Mostafa Osman, Amira I Hamid, Ashraf Mohammad Al-Breedy, Hoda A Abdelsattar

Open access · goldAbstract read
In one paragraph

Article in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Scaling concepts in 'omics: Nuclear lamin-B scales with tumor growth and often predicts poor prognosis, unlike fibrosis.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amani M AbdelghanyDepartment of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Nasser Sadek RezkDepartment of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Mona Mostafa OsmanDepartment of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Amira I HamidDepartment of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Ashraf Mohammad Al-BreedyDepartment of Tropical Medicine and Infectious Diseases, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Hoda A AbdelsattarDepartment of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.ORCID 0000-0002-5883-8207
Ain Shams University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver Neoplasmsalpha-FetoproteinsCross-Sectional StudiesEarly Detection of CancerEgyptHumansLamin Type BRNA, Messengeralpha-FetoproteinsLamin Type BRNA, MessengerAFPHepatocellular carcinomalamin B1RT-qPCR

Identifiers

PMID30467522
PMCPMC6208568
OpenAlexW2888493524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.